Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/1998
05/19/1998US5753256 Plaster for the treatment of nail mycoses
05/19/1998US5753235 Recombinant canine herpesviruses
05/19/1998US5753221 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
05/14/1998WO1998020161A1 Methods for identifying genes essential to the growth of an organism
05/14/1998WO1998020142A1 Notch
05/14/1998WO1998020095A2 Washing disinfectant for hygienic and surgical hand disinfection
05/14/1998WO1998020036A1 Constrained helical peptides and methods of making same
05/14/1998WO1998020017A1 Modified nucleoside-5'-triphosphates
05/14/1998WO1998020016A1 Novel coding sequences from herpes simplex virus type-2
05/14/1998WO1998020013A1 New knoevenagel condensation products, method for their production and their use
05/14/1998WO1998020009A1 (4r,5s,6s,7r)-hexahydro-1- [5-(3-aminoinazole)methyl] -3-butyl-5,6-dihydroxy-4,7-bis [phaenylmethyl] -2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor
05/14/1998WO1998020008A1 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors
05/14/1998WO1998020007A1 Quinolines and their therapeutic use
05/14/1998WO1998019999A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
05/14/1998WO1998019997A2 Dihydropyrones with improved antiviral activity
05/14/1998WO1998019704A1 Human monoclonal antibodies
05/14/1998WO1998019694A1 Therapeutic uses of bpi protein products in cystic fibrosis patients
05/14/1998WO1998019689A1 Novel coding sequences
05/14/1998WO1998019649A2 Methods and compositions for inhibition of angiogenesis
05/14/1998WO1998019648A2 N-oxy-naphthalimides as antibacterial agents
05/14/1998WO1998009647A3 Cyanidin compositions and therapeutic and diagnostic uses therefor
05/14/1998WO1998007859A3 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998006415A3 Anti-chlamydial methods and materials
05/14/1998WO1998005776A3 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998004286A3 Assembly-deficient herpesvirus vaccine
05/14/1998WO1998001558A3 Protein and peptide vaccines for inducing mucosal immunity
05/14/1998WO1997044054A3 Type-2 chemokine binding proteins and methods of use therefor
05/14/1998WO1997041822A3 Anti-viral compounds
05/14/1998CA2270973A1 New knoevenagel condensation products, method for their production and their use
05/14/1998CA2270966A1 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors
05/14/1998CA2270963A1 (4r,5s,6s,7r)-hexahydro-1- [5-(3-aminoinazole)methyl] -3-butyl-5,6-dihydroxy-4,7-bis [phaenylmethyl] -2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor
05/14/1998CA2270869A1 Constrained helical peptides and methods of making same
05/14/1998CA2270290A1 Therapeutic uses of bpi protein products in cystic fibrosis patients
05/14/1998CA2270288A1 Human monoclonal antibodies
05/14/1998CA2270282A1 Novel coding sequences from herpes simplex virus type-2
05/14/1998CA2270153A1 Methods for identifying genes essential to the growth of an organism
05/14/1998CA2268126A1 Quinolines and their therapeutic use
05/14/1998CA2263429A1 Dihydropyrones with improved antiviral activity
05/14/1998CA2263301A1 Isoquinolones
05/13/1998EP0841399A2 Mammalian fin-1 nucleic acid (a caspase) and protein sequences and uses therefor
05/13/1998EP0841394A2 Staphylococcus aureus polynucleotides, polypeptides and their uses
05/13/1998EP0841339A1 Vinylpyrrolidinon cephalosporin derivatives
05/13/1998EP0841064A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections
05/13/1998EP0840747A1 Papillomavirus polyprotein constructs
05/13/1998EP0840620A1 Il-8 antagonists for treatment of inflammatory disorders and asthma
05/13/1998EP0840615A2 Chemokine binding protein and methods of use therefor
05/13/1998EP0840606A1 Di- and trivalent small molecule selectin inhibitors
05/13/1998EP0688222B1 Therapeutic compositions containing a lithium compound and silica
05/13/1998EP0606382B1 1,8-benzonaphthyridine derivatives and antimicrobial compositions
05/13/1998EP0599881B1 Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them
05/13/1998EP0573614B1 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
05/13/1998EP0375736B1 Nucleic acid fragments encoding mannose binding fragments of human mannose binding protein
05/13/1998CN1181783A Medical composition
05/13/1998CN1181761A Antigen compsn. against mycoplasma
05/13/1998CN1181755A THF-containing sulfonamide inhibitors of aspartyl protease
05/13/1998CN1181752A Process for the prepn. of 2, 2' -bipyrrolyl-pyrromethene (prodigiosins) derivatives
05/13/1998CN1181701A Pharmaceutical compsn. containing N-chlorophenylcar-bamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses andcancers
05/13/1998CN1181387A Novel polyhydro derivatives of tylosine and process for their preparation
05/13/1998CN1181382A Vinylpyrrolidinon cephalosporin derivatives
05/13/1998CN1038327C Process for prepn. of cephalosporin derivative
05/12/1998US5750735 Chemical intermediates for antibiotics
05/12/1998US5750673 Nucleosides with 2'-O-modifications
05/12/1998US5750669 Nuclease-stable antiviral agents which can suppress synthesis of antigens and gene expression of proteins
05/12/1998US5750664 Substituted liposaccharides useful in the treatment and prevention of endotoxemia
05/12/1998US5750573 Guanylhydrazones and their use to treat inflammatory conditions
05/12/1998US5750555 Bis-indolyl maleinimide or indolopyrrolo carbazole containing an amino acid as PKC inhibitors
05/12/1998US5750551 Angiotensin inhibitors, benzimidazole derivatives
05/12/1998US5750527 Viricides
05/12/1998US5750503 Administering synergistic mixture of granulocyte colony stimulating factor (g-csf) and tumor necrosis factor binding protein (tnf-bp) lacking first domain of constant region of heavy chain of human immunoglobulin igg1 or igg3
05/12/1998US5750493 Alpha-1-acid glycoprotein binders
05/12/1998US5750398 Vector, element and method for inhibiting immune recognition
05/12/1998US5750394 Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
05/12/1998US5750387 DNA encoing leucyl TRNA synthetase from staphylococcus aureus
05/12/1998US5750350 Kit containing antibodies
05/12/1998US5750113 An isolated infectious bronchitis virus (ibv) of the same serotype as that of the ibv strain 4/91 deposit; attenuation
05/12/1998US5750111 Mild newcastle disease virus vaccine
05/12/1998CA1339860C Derivatives of penem
05/07/1998WO1998018947A1 Methods for the characterization and selection of rna target motifs that bind compounds of pharmaceutical use
05/07/1998WO1998018931A2 Streptococcus pneumoniae polynucleotides and sequences
05/07/1998WO1998018930A2 Streptococcus pneumoniae antigens and vaccines
05/07/1998WO1998018928A1 Immunogenic detoxified mutant e. coli lt-a toxin
05/07/1998WO1998018924A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists
05/07/1998WO1998018917A2 RIBOFLAVIN MUTANTS AS VACCINES AGAINST $i(ACTINOBACILLUS PLEUROPNEUMONIAE)
05/07/1998WO1998018810A1 Immunostimulatory nucleic acid molecules
05/07/1998WO1998018807A1 Erythromycin a derivatives
05/07/1998WO1998018800A1 Stabilized carbapenem antibiotic compositions and method of making
05/07/1998WO1998018487A1 Prophylactic/remedial agent
05/07/1998WO1998018477A2 Pharmaceutical compositions containing lamivudine and zidovudine
05/07/1998WO1998018472A1 Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators
05/07/1998WO1998018468A1 Synergistic composition comprising rapamycin and calcitriol
05/07/1998WO1998018457A1 Use of adamantane amines or structurally similar compounds for combating borna disease virus and for the prevention and treatment of affective diseases and other disorders associated with bdv infections in humans and animals
05/07/1998WO1998018326A1 Compounds, compositions and methods for treating antibiotic-resistant infections
05/07/1998WO1998018324A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna
05/07/1998WO1998018323A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
05/07/1998WO1998008856A3 Mirror-symmetrical selection and evolution of nucleic acids
05/07/1998WO1998000173A3 Targeted drug delivery using sulfonamide derivatives
05/07/1998CA2271720A1 Streptococcus pneumoniae polynucleotides and sequences
05/07/1998CA2270373A1 Synergistic composition comprising rapamycin and calcitriol
05/07/1998CA2270345A1 Immunostimulatory nucleic acid molecules
05/07/1998CA2270254A1 Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators
1 ... 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 ... 1798